Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;130(1):42-46.
doi: 10.1097/AOG.0000000000002094.

A Shared Decision-Making Intervention to Guide Opioid Prescribing After Cesarean Delivery

Affiliations

A Shared Decision-Making Intervention to Guide Opioid Prescribing After Cesarean Delivery

Malavika Prabhu et al. Obstet Gynecol. 2017 Jul.

Abstract

Objective: To assess whether a shared decision-making intervention decreases the quantity of oxycodone tablets prescribed after cesarean delivery.

Technique: A tablet computer-based decision aid formed the basis of a shared decision-making session to guide opioid prescribing after cesarean delivery. Women first received information on typical trajectories of pain resolution and expected opioid use after cesarean delivery and then chose the number of tablets of 5 mg oxycodone they would be prescribed up to the institutional standard prescription of 40 tablets.

Experience: From April 11, 2016, to June 10, 2016, 105 women were screened, 75 were eligible, and 51 consented to participate; one patient was excluded after enrollment as a result of prolonged hospitalization. The median number of tablets (5 mg oxycodone) women chose for their prescription was 20.0 (interquartile range 15.0-25.0), which was less than the standard 40-tablet prescription (P<.001).

Conclusion: A shared decision-making approach to opioid prescribing after cesarean delivery was associated with approximately a 50% decrease in the number of opioids prescribed postoperatively in this cohort compared with our institutional standard prescription. This approach is a promising strategy to reduce the amount of leftover opioid medication after treatment of acute postcesarean pain.

Clinical trial registration: ClinicalTrials.gov, NCT02770612.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flowchart

Similar articles

Cited by

References

    1. Hamilton BE, Martin JA, Osterman MJ, Curtin SC, Matthews TJ. Births: Final data for 2014. Natl Vital Stat Rep. 2015;64:1. - PubMed
    1. Bateman BT, Huybrechts KF, Booth J, Briggs H, Flood P, Bauer M, Landau R. Opioid Use Following Discharge After Cesarean Delivery. Pharmacoepidemiology and drug safety; Abstracts of the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25–28, 2016; Dublin, Ireland: The Convention Centre Dublin; 2016. pp. 3–680. - DOI
    1. Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban community: the result of an ultrarapid assessment. Pain Med. 2009;10:537–48. - PMC - PubMed
    1. McCabe SE, West BT, Teter CJ, Boyd CJ. Medical and nonmedical use of prescription opioids among high school seniors in the United States. Arch Pediatr Adolesc Med. 2012;166:797–802. - PMC - PubMed
    1. Kennedy-Hendricks A, Gielen A, McDonald E, McGinty EE, Shields W, Barry CL. Medication sharing, storage, and disposal practices for opioid medications among US adults. JAMA Intern Med. 2016;176:1027. - PubMed

Publication types

Substances

Associated data